img

Global and United States CD55 Antibody Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States CD55 Antibody Market Report & Forecast 2024-2034

CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
Market Analysis and InsightsGlobal and United States CD55 Antibody Market
This report focuses on global and United States CD55 Antibody market, also covers the segmentation data of other regions in regional level and county level.
The global CD55 Antibody revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the CD55 Antibody revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of CD55 Antibody include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci and Bethyl Laboratories, etc. The global five biggest players hold a share of % in 2022.
Global CD55 Antibody Scope and Market Size
CD55 Antibody market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global CD55 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the CD55 Antibody market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
Leading Biology
ProSci
Bethyl Laboratories
OriGene Technologies
Novus Biologicals
Cell Signaling Technology
Abcam
GeneTex
United States Biological
St John's Laboratory
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces CD55 Antibody definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of CD55 Antibody companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of CD55 Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CD55 Antibody revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 CD55 Antibody Product Introduction
1.2 Global CD55 Antibody Outlook 2018 VS 2022 VS 2033
1.2.1 Global CD55 Antibody Market Size for the Year 2018-2033
1.2.2 United States CD55 Antibody Market Size for the Year 2018-2033
1.3 CD55 Antibody Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States CD55 Antibody in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of CD55 Antibody Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 CD55 Antibody Market Dynamics
1.4.1 CD55 Antibody Industry Trends
1.4.2 CD55 Antibody Market Drivers
1.4.3 CD55 Antibody Market Challenges
1.4.4 CD55 Antibody Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 CD55 Antibody by Type
2.1 CD55 Antibody Market Segment by Type
2.1.1 Monoclonal
2.1.2 Polyclonal
2.2 Global CD55 Antibody Market Size by Type (2018, 2022 & 2033)
2.3 Global CD55 Antibody Market Size by Type (2018-2033)
2.4 United States CD55 Antibody Market Size by Type (2018, 2022 & 2033)
2.5 United States CD55 Antibody Market Size by Type (2018-2033)
3 CD55 Antibody by Application
3.1 CD55 Antibody Market Segment by Application
3.1.1 Immunochemistry (IHC)
3.1.2 Immunofluorescence (IF)
3.1.3 Immunoprecipitation (IP)
3.1.4 Western Blot (WB)
3.1.5 ELISA
3.1.6 Others
3.2 Global CD55 Antibody Market Size by Application (2018, 2022 & 2033)
3.3 Global CD55 Antibody Market Size by Application (2018-2033)
3.4 United States CD55 Antibody Market Size by Application (2018, 2022 & 2033)
3.5 United States CD55 Antibody Market Size by Application (2018-2033)
4 Global CD55 Antibody Competitor Landscape by Company
4.1 Global CD55 Antibody Market Size by Company
4.1.1 Global Key Companies of CD55 Antibody, Ranked by Revenue (2022)
4.1.2 Global CD55 Antibody Revenue by Player (2018-2023)
4.2 Global CD55 Antibody Concentration Ratio (CR)
4.2.1 CD55 Antibody Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of CD55 Antibody in 2022
4.2.3 Global CD55 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of CD55 Antibody Head office and Area Served
4.4 Global Key Players of CD55 Antibody, Product and Application
4.5 Global Key Players of CD55 Antibody, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States CD55 Antibody Market Size by Company
4.7.1 Key Players of CD55 Antibody in United States, Ranked by Revenue (2022)
4.7.2 United States CD55 Antibody Revenue by Players (2021, 2022 & 2023)
5 Global CD55 Antibody Market Size by Region
5.1 Global CD55 Antibody Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global CD55 Antibody Market Size by Region (2018-2033)
5.2.1 Global CD55 Antibody Market Size by Region: 2018-2023
5.2.2 Global CD55 Antibody Market Size by Region (2024-2033)
6 Americas
6.1 Americas CD55 Antibody Market Size YoY Growth 2018-2033
6.2 Americas CD55 Antibody Market Size by Type
6.2.1 Americas CD55 Antibody Market Size by Type (2018-2023)
6.2.2 Americas CD55 Antibody Market Size by Type (2024-2033)
6.2.3 Americas CD55 Antibody Market Share by Type (2018-2033)
6.3 Americas CD55 Antibody Market Size by Application
6.3.1 Americas CD55 Antibody Market Size by Application (2018-2023)
6.3.2 Americas CD55 Antibody Market Size by Application (2024-2033)
6.3.3 Americas CD55 Antibody Market Share by Application (2018-2033)
6.4 Americas CD55 Antibody Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA CD55 Antibody Market Size YoY Growth 2018-2033
7.2 EMEA CD55 Antibody Market Size by Type
7.2.1 EMEA CD55 Antibody Market Size by Type (2018-2023)
7.2.2 EMEA CD55 Antibody Market Size by Type (2024-2033)
7.2.3 EMEA CD55 Antibody Market Share by Type (2018-2033)
7.3 EMEA CD55 Antibody Market Size by Application
7.3.1 EMEA CD55 Antibody Market Size by Application (2018-2023)
7.3.2 EMEA CD55 Antibody Market Size by Application (2024-2033)
7.3.3 EMEA CD55 Antibody Market Share by Application (2018-2033)
7.4 EMEA CD55 Antibody Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China CD55 Antibody Market Size YoY Growth 2018-2033
8.2 China CD55 Antibody Market Size by Type
8.2.1 China CD55 Antibody Market Size by Type (2018-2023)
8.2.2 China CD55 Antibody Market Size by Type (2024-2033)
8.2.3 China CD55 Antibody Market Share by Type (2018-2033)
8.3 China CD55 Antibody Market Size by Application
8.3.1 China CD55 Antibody Market Size by Application (2018-2023)
8.3.2 China CD55 Antibody Market Size by Application (2024-2033)
8.3.3 China CD55 Antibody Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC CD55 Antibody Market Size YoY Growth 2018-2033
9.2 APAC CD55 Antibody Market Size by Type
9.2.1 APAC CD55 Antibody Market Size by Type (2018-2023)
9.2.2 APAC CD55 Antibody Market Size by Type (2024-2033)
9.2.3 APAC CD55 Antibody Market Share by Type (2018-2033)
9.3 APAC CD55 Antibody Market Size by Application
9.3.1 APAC CD55 Antibody Market Size by Application (2018-2023)
9.3.2 APAC CD55 Antibody Market Size by Application (2024-2033)
9.3.3 APAC CD55 Antibody Market Share by Application (2018-2033)
9.4 APAC CD55 Antibody Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Merck Business Overview
10.1.3 Merck CD55 Antibody Introduction
10.1.4 Merck Revenue in CD55 Antibody Business (2018-2023)
10.1.5 Merck Recent Development
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Company Details
10.2.2 Thermo Fisher Scientific Business Overview
10.2.3 Thermo Fisher Scientific CD55 Antibody Introduction
10.2.4 Thermo Fisher Scientific Revenue in CD55 Antibody Business (2018-2023)
10.2.5 Thermo Fisher Scientific Recent Development
10.3 Proteintech Group
10.3.1 Proteintech Group Company Details
10.3.2 Proteintech Group Business Overview
10.3.3 Proteintech Group CD55 Antibody Introduction
10.3.4 Proteintech Group Revenue in CD55 Antibody Business (2018-2023)
10.3.5 Proteintech Group Recent Development
10.4 Aviva Systems Biology
10.4.1 Aviva Systems Biology Company Details
10.4.2 Aviva Systems Biology Business Overview
10.4.3 Aviva Systems Biology CD55 Antibody Introduction
10.4.4 Aviva Systems Biology Revenue in CD55 Antibody Business (2018-2023)
10.4.5 Aviva Systems Biology Recent Development
10.5 LifeSpan BioSciences
10.5.1 LifeSpan BioSciences Company Details
10.5.2 LifeSpan BioSciences Business Overview
10.5.3 LifeSpan BioSciences CD55 Antibody Introduction
10.5.4 LifeSpan BioSciences Revenue in CD55 Antibody Business (2018-2023)
10.5.5 LifeSpan BioSciences Recent Development
10.6 RayBiotech
10.6.1 RayBiotech Company Details
10.6.2 RayBiotech Business Overview
10.6.3 RayBiotech CD55 Antibody Introduction
10.6.4 RayBiotech Revenue in CD55 Antibody Business (2018-2023)
10.6.5 RayBiotech Recent Development
10.7 Leading Biology
10.7.1 Leading Biology Company Details
10.7.2 Leading Biology Business Overview
10.7.3 Leading Biology CD55 Antibody Introduction
10.7.4 Leading Biology Revenue in CD55 Antibody Business (2018-2023)
10.7.5 Leading Biology Recent Development
10.8 ProSci
10.8.1 ProSci Company Details
10.8.2 ProSci Business Overview
10.8.3 ProSci CD55 Antibody Introduction
10.8.4 ProSci Revenue in CD55 Antibody Business (2018-2023)
10.8.5 ProSci Recent Development
10.9 Bethyl Laboratories
10.9.1 Bethyl Laboratories Company Details
10.9.2 Bethyl Laboratories Business Overview
10.9.3 Bethyl Laboratories CD55 Antibody Introduction
10.9.4 Bethyl Laboratories Revenue in CD55 Antibody Business (2018-2023)
10.9.5 Bethyl Laboratories Recent Development
10.10 OriGene Technologies
10.10.1 OriGene Technologies Company Details
10.10.2 OriGene Technologies Business Overview
10.10.3 OriGene Technologies CD55 Antibody Introduction
10.10.4 OriGene Technologies Revenue in CD55 Antibody Business (2018-2023)
10.10.5 OriGene Technologies Recent Development
10.11 Novus Biologicals
10.11.1 Novus Biologicals Company Details
10.11.2 Novus Biologicals Business Overview
10.11.3 Novus Biologicals CD55 Antibody Introduction
10.11.4 Novus Biologicals Revenue in CD55 Antibody Business (2018-2023)
10.11.5 Novus Biologicals Recent Development
10.12 Cell Signaling Technology
10.12.1 Cell Signaling Technology Company Details
10.12.2 Cell Signaling Technology Business Overview
10.12.3 Cell Signaling Technology CD55 Antibody Introduction
10.12.4 Cell Signaling Technology Revenue in CD55 Antibody Business (2018-2023)
10.12.5 Cell Signaling Technology Recent Development
10.13 Abcam
10.13.1 Abcam Company Details
10.13.2 Abcam Business Overview
10.13.3 Abcam CD55 Antibody Introduction
10.13.4 Abcam Revenue in CD55 Antibody Business (2018-2023)
10.13.5 Abcam Recent Development
10.14 GeneTex
10.14.1 GeneTex Company Details
10.14.2 GeneTex Business Overview
10.14.3 GeneTex CD55 Antibody Introduction
10.14.4 GeneTex Revenue in CD55 Antibody Business (2018-2023)
10.14.5 GeneTex Recent Development
10.15 United States Biological
10.15.1 United States Biological Company Details
10.15.2 United States Biological Business Overview
10.15.3 United States Biological CD55 Antibody Introduction
10.15.4 United States Biological Revenue in CD55 Antibody Business (2018-2023)
10.15.5 United States Biological Recent Development
10.16 St John's Laboratory
10.16.1 St John's Laboratory Company Details
10.16.2 St John's Laboratory Business Overview
10.16.3 St John's Laboratory CD55 Antibody Introduction
10.16.4 St John's Laboratory Revenue in CD55 Antibody Business (2018-2023)
10.16.5 St John's Laboratory Recent Development
10.17 Creative Diagnostics
10.17.1 Creative Diagnostics Company Details
10.17.2 Creative Diagnostics Business Overview
10.17.3 Creative Diagnostics CD55 Antibody Introduction
10.17.4 Creative Diagnostics Revenue in CD55 Antibody Business (2018-2023)
10.17.5 Creative Diagnostics Recent Development
10.18 Biobyt
10.18.1 Biobyt Company Details
10.18.2 Biobyt Business Overview
10.18.3 Biobyt CD55 Antibody Introduction
10.18.4 Biobyt Revenue in CD55 Antibody Business (2018-2023)
10.18.5 Biobyt Recent Development
10.19 Jingjie PTM BioLab
10.19.1 Jingjie PTM BioLab Company Details
10.19.2 Jingjie PTM BioLab Business Overview
10.19.3 Jingjie PTM BioLab CD55 Antibody Introduction
10.19.4 Jingjie PTM BioLab Revenue in CD55 Antibody Business (2018-2023)
10.19.5 Jingjie PTM BioLab Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. CD55 Antibody Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. CD55 Antibody Market Trends
Table 3. CD55 Antibody Market Drivers
Table 4. CD55 Antibody Market Challenges
Table 5. CD55 Antibody Market Restraints
Table 6. Global CD55 Antibody Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States CD55 Antibody Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global CD55 Antibody Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States CD55 Antibody Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of CD55 Antibody, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global CD55 Antibody Revenue by Player, (US$ Million), 2018-2023
Table 12. Global CD55 Antibody Revenue Share by Player, 2018-2023
Table 13. Global CD55 Antibody Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD55 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2022)
Table 15. Global Key Players of CD55 Antibody, Headquarters and Area Served
Table 16. Global Key Players of CD55 Antibody, Product and Application
Table 17. Global Key Players of CD55 Antibody, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of CD55 Antibody in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States CD55 Antibody Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States CD55 Antibody Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global CD55 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global CD55 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global CD55 Antibody Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas CD55 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas CD55 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas CD55 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA CD55 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA CD55 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA CD55 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 39. China CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 40. China CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 41. China CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 42. China CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 43. China CD55 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC CD55 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC CD55 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC CD55 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck CD55 Antibody Product
Table 54. Merck Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific CD55 Antibody Product
Table 59. Thermo Fisher Scientific Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Proteintech Group Company Details
Table 62. Proteintech Group Business Overview
Table 63. Proteintech Group CD55 Antibody Product
Table 64. Proteintech Group Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 65. Proteintech Group Recent Development
Table 66. Aviva Systems Biology Company Details
Table 67. Aviva Systems Biology Business Overview
Table 68. Aviva Systems Biology CD55 Antibody Product
Table 69. Aviva Systems Biology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 70. Aviva Systems Biology Recent Development
Table 71. LifeSpan BioSciences Company Details
Table 72. LifeSpan BioSciences Business Overview
Table 73. LifeSpan BioSciences CD55 Antibody Product
Table 74. LifeSpan BioSciences Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 75. LifeSpan BioSciences Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD55 Antibody Product
Table 79. RayBiotech Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. Leading Biology Company Details
Table 82. Leading Biology Business Overview
Table 83. Leading Biology CD55 Antibody Product
Table 84. Leading Biology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 85. Leading Biology Recent Development
Table 86. ProSci Company Details
Table 87. ProSci Business Overview
Table 88. ProSci CD55 Antibody Product
Table 89. ProSci Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 90. ProSci Recent Development
Table 91. Bethyl Laboratories Company Details
Table 92. Bethyl Laboratories Business Overview
Table 93. Bethyl Laboratories CD55 Antibody Product
Table 94. Bethyl Laboratories Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 95. Bethyl Laboratories Recent Development
Table 96. OriGene Technologies Company Details
Table 97. OriGene Technologies Business Overview
Table 98. OriGene Technologies CD55 Antibody Product
Table 99. OriGene Technologies Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 100. OriGene Technologies Recent Development
Table 101. Novus Biologicals Company Details
Table 102. Novus Biologicals Business Overview
Table 103. Novus Biologicals CD55 Antibody Product
Table 104. Novus Biologicals Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 105. Novus Biologicals Recent Development
Table 106. Cell Signaling Technology Company Details
Table 107. Cell Signaling Technology Business Overview
Table 108. Cell Signaling Technology CD55 Antibody Product
Table 109. Cell Signaling Technology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 110. Cell Signaling Technology Recent Development
Table 111. Abcam Company Details
Table 112. Abcam Business Overview
Table 113. Abcam CD55 Antibody Product
Table 114. Abcam Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 115. Abcam Recent Development
Table 116. GeneTex Company Details
Table 117. GeneTex Business Overview
Table 118. GeneTex CD55 Antibody Product
Table 119. GeneTex Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 120. GeneTex Recent Development
Table 121. United States Biological Company Details
Table 122. United States Biological Business Overview
Table 123. United States Biological CD55 Antibody Product
Table 124. United States Biological Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 125. United States Biological Recent Development
Table 126. St John's Laboratory Company Details
Table 127. St John's Laboratory Business Overview
Table 128. St John's Laboratory CD55 Antibody Product
Table 129. St John's Laboratory Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 130. St John's Laboratory Recent Development
Table 131. Creative Diagnostics Company Details
Table 132. Creative Diagnostics Business Overview
Table 133. Creative Diagnostics CD55 Antibody Product
Table 134. Creative Diagnostics Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 135. Creative Diagnostics Recent Development
Table 136. Biobyt Company Details
Table 137. Biobyt Business Overview
Table 138. Biobyt CD55 Antibody Product
Table 139. Biobyt Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 140. Biobyt Recent Development
Table 141. Jingjie PTM BioLab Company Details
Table 142. Jingjie PTM BioLab Business Overview
Table 143. Jingjie PTM BioLab CD55 Antibody Product
Table 144. Jingjie PTM BioLab Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 145. Jingjie PTM BioLab Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. CD55 Antibody Product Picture
Figure 2. Global CD55 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global CD55 Antibody Market Size 2018-2033 (US$ Million)
Figure 4. United States CD55 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States CD55 Antibody Market Size 2018-2033 (US$ Million)
Figure 6. United States CD55 Antibody Market Share in Global 2018-2033
Figure 7. CD55 Antibody Report Years Considered
Figure 8. Product Picture of Monoclonal
Figure 9. Product Picture of Polyclonal
Figure 10. Global CD55 Antibody Market Share by Type in 2022 & 2033
Figure 11. Global CD55 Antibody Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global CD55 Antibody Market Share by Type (2018-2033)
Figure 13. United States CD55 Antibody Market Share by Type in 2022 & 2033
Figure 14. United States CD55 Antibody Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States CD55 Antibody Market Share by Type (2018-2033)
Figure 16. Product Picture of Immunochemistry (IHC)
Figure 17. Product Picture of Immunofluorescence (IF)
Figure 18. Product Picture of Immunoprecipitation (IP)
Figure 19. Product Picture of Western Blot (WB)
Figure 20. Product Picture of ELISA
Figure 21. Product Picture of Others
Figure 22. Global CD55 Antibody Market Share by Application in 2022 & 2033
Figure 23. Global CD55 Antibody Market Size by Application (2018-2033) & (US$ Million)
Figure 24. Global CD55 Antibody Market Share by Application (2018-2033)
Figure 25. United States CD55 Antibody Market Share by Application in 2022 & 2033
Figure 26. United States CD55 Antibody Market Size by Application (2018-2033) & (US$ Million)
Figure 27. United States CD55 Antibody Market Share by Application (2018-2033)
Figure 28. The Top 5 and 10 Largest Companies of CD55 Antibody in the World: Market Share by CD55 Antibody Revenue in 2022
Figure 29. Global CD55 Antibody Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 30. Global CD55 Antibody Market Share by Region (2018-2033)
Figure 31. Americas CD55 Antibody Market Size Growth Rate 2018-2033 (US$ Million)
Figure 32. Americas CD55 Antibody Market Share by Type (2018-2033)
Figure 33. Americas CD55 Antibody Market Share by Application (2018-2033)
Figure 34. United States CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Canada CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Mexico CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. Brazil CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 38. EMEA CD55 Antibody Market Size Growth Rate 2018-2033 (US$ Million)
Figure 39. EMEA CD55 Antibody Market Share by Type (2018-2033)
Figure 40. EMEA CD55 Antibody Market Share by Application (2018-2033)
Figure 41. Europe CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Middle East CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. Africa CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 44. China CD55 Antibody Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. China CD55 Antibody Market Share by Type (2018-2033)
Figure 46. China CD55 Antibody Market Share by Application (2018-2033)
Figure 47. APAC CD55 Antibody Market Size Growth Rate 2018-2033 (US$ Million)
Figure 48. APAC CD55 Antibody Market Share by Type (2018-2033)
Figure 49. APAC CD55 Antibody Market Share by Application (2018-2033)
Figure 50. Japan CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. South Korea CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. China Taiwan CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Southeast Asia CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. India CD55 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 55. Merck Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 57. Proteintech Group Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 58. Aviva Systems Biology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 59. LifeSpan BioSciences Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 60. RayBiotech Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 61. Leading Biology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 62. ProSci Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 63. Bethyl Laboratories Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 64. OriGene Technologies Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 65. Novus Biologicals Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 66. Cell Signaling Technology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 67. Abcam Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 68. GeneTex Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 69. United States Biological Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 70. St John's Laboratory Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 71. Creative Diagnostics Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 72. Biobyt Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 73. Jingjie PTM BioLab Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed